SK bioscience Secures Funding to Advance RSV Preventive Antibody Development with RIGHT Foundation Support
Largest-ever grant from RIGHT Foundation to accelerate Phase 1b clinical trial of RSV preventive antibody Technology licensed from Gates MRI; early studies confirm suppression of RSV infection Targeting global markets while addressing unmet needs in developing countries INCHEON, South...
CP
cision pr newswire
via Pr Newswire - Corroborated by 1 others
Updated 22h ago

Source Verification
Corroboration Score: 2This story was independently reported by 2 sources. Click any source to read the original article.
Comments
0 commentsBe respectful and constructive.
Loading comments...
Previous
My 'panic attacks' turned out to be much more serious - I needed brain surgery
Next

